Symbol
CHRS on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
6,009,514 shares
Security Ownership %
5.2%

Thomas A. Satterfield, Jr. ownership in Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS)

16 Apr 2025 - Thomas A. Satterfield, Jr. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,009,514 shares of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS). This represents 5.2% ownership of the company. This is the first filing by Thomas A. Satterfield Jr. disclosing ownership of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS).